| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $37.9M | +59.9% |
| Cost of Revenue | $26.0M | +99.2% |
| R&D Expense | $50.3M | +80.9% |
| SG&A Expense | $78.4M | +52.5% |
| Operating Income | -$123.6M | -80.5% |
| Pre-tax Income | $50.1M | +132.8% |
| Income Tax | -$22.8M | — |
| Net Income | $73.9M | +148.4% |
| EPS (Basic) | $0.55 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $110.3M | -58.9% |
| Accounts Receivable | $9.1M | +10.5% |
| Inventory | $19.1M | +59.1% |
| Current Assets | $142.1M | -51.2% |
| Total Assets | $425.3M | +43.9% |
| Current Liabilities | $20.4M | +89.7% |
| Long-term Debt | $0 | -100.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$44.5M | -6.7% |
| Capital Expenditures | $4.6M | +124.6% |
| Investing Cash Flow | -$107.6M | -3004.7% |
| Financing Cash Flow | -$5.8M | -102.1% |
| Free Cash Flow | -$49.1M | -12.3% |
| +114.1% |
| EPS (Diluted) | $0.51 | +113.1% |
| Total Liabilities |
| $40.5M |
| -82.4% |
| Stockholders' Equity | $381.1M | +481.6% |